MESSAGE
| DATE | 2013-03-28 |
| FROM | Ruben Safir
|
| SUBJECT | Subject: [NYLXS - HANGOUT] [info@rxinsider411.com: ICS Prescription Formulary Coverage Change]
|
Let us celebrate upon this urgent news from your insurance company!
----- Forwarded message from RXinsider 411 -----
Date: Thu, 28 Mar 2013 17:47:50 -0400
From: RXinsider 411
To: "ruben-at-nylxs.com"
Subject: ICS Prescription Formulary Coverage Change
X-Mailer: Oempro4
View this email online:
http://rphmail.com/ch/2013/qvar_022513.html
Rx FORMULARY COVERAGE CHANGE
EFFECTIVE JANUARY 1, 2013
Preferred Rx Formulary Coverage December January
by percent of covered lives 2012[1] 2013[2]
QVAR? 92% -> 92%
(belcomethasone dipropionate HFA)
Flovent? HFA 90% -> 67%
*QVAR is not the only agent in its class with Preferred Rx Formulary Status on Medco
and Express Scripts. Please review complete Rx Formulary Status at the PBM?s website.
MORE INSURED PATIENTS MAY PAY LESS FOR QVAR[2]
Indication
QVAR (beclomethasone dipropionate HFA) Inhalation Aerosol is
indicated in the maintenance treatment of asthma as prophylactic
therapy in patients 5 years of age or older. QVAR is also
indicated for asthma patients who require systemic corticosteroid
administration, where adding QVAR may reduce or eliminate the need
for systemic corticosteroids.
Important Safety Information
? QVAR is not a bronchodilator and is not indicated for relief of
acute bronchospasm.
CAUTION: Adrenal insufficiency may occur when transferring patients
from systemic steroids (see WARNINGS, Prescribing Information).
? A reduction in growth velocity in growing children and teenagers
may occur as a result of inadequate control of chronic diseases
such as asthma or from use of corticosteroids for treatment.
? Common side effects associated with the use of QVAR and placebo
in clinical trials include, but are not limited to, headache
(12% and 9% respectively) and pharyngitis (8% and 4% respectively).
Please see full Prescribing Information.
http://qvar.com/library/docs/prescribing-information.pdf
REFERENCES: 1. Fingertip Formulary?. Glen Rock, NJ: Fingertip
Formulary, LLC; December 2012. 2. Fingertip Formulary?. Glen Rock,
NJ: Fingertip Formulary, LLC; January 2013.
QVAR? is a registered trademark of IVAX LLC, a member of the
Teva Group. The brands listed are the registered trademarks of
their respective owners. ?2013 Teva Respiratory, LLC. QVA-40016
We hope you found this message to be useful. However,
if you prefer not to receive future emails from us,
please visit http://rxinsider.net/users/opt_out.php
to discontinue service.
RXinsider | 1300 Division Rd | West Warwick | RI | 02893
----- End forwarded message -----
|
|
